Table of Contents Table of Contents
Previous Page  20 / 88 Next Page
Information
Show Menu
Previous Page 20 / 88 Next Page
Page Background

WFSBP 2017

20

Scientific Programme Schedule /

Wednesday, 21 June 2017

Auditorium

15

Congress

Hall A3

Auditorium

12

Auditorium

10

Auditorium

11

B3 M1–M2 B3 M3–M4 Congress

Hall A1

8:30 S-43

Novel ap-

proaches in

mechanisms

of action of

antidepressant

treatment

S-44

Cannabinoid

Receptor (CBR)

gene variations

in neuropsy-

chiatric dis-

orders

FC-09

Depression 1

S-45

Behavioral

Addictions:

Diagnosis,

co-morbidity

and neuro-

biology

S-46

Neurobiology

and psycho-

pharmacology

of aggressive be-

haviour: Where

are we?

S-47

Catecolamines,

anhedonia and

depression

FC-10

Antipsychotics 2

9:00

9:30

10:00

Coffee Break

PL-03

Epigenetic

consequences of

early adversity

10:30

11:00

D-03

Deep brain

stimulation is

a worthwhile

treatment

method in

psychiatry

TFS-07

Enhancing the

role of primary

care in looking

after people

with mental

health problems

S-48

Pharmacoge-

netics of drug

defense and

neuroprotec-

tion: From the

Neandertal to

the modern

humans

S-49

Evidence-based

guidelines for

treatment of

major depres-

sive disorder:

Contrasting

views across the

world

S-50

Real time

assessment of

psychopatholo-

gy and behavior

in Bipolar Dis-

order (BP) using

e-mental health

technologies

WS-09

Schizophrenia

research in

Chile

11:30

12:00

12:30

13:00

WFSBP

General

Assembly

Guided

Poster Tours

P-11 – P-17

13:30

14:00

14:30

15:00 S-51

Advances in

biomarker

development

for neurostimu-

lation

TFS-08

Men's mental

health: Contem-

porary aspects

TFW-03

WFSBP Treat-

ment Guideline

Session: Do

bipolar mixed

states merit

a treatment

guideline on its

own?

S-52

The G protein

coupled recep-

tors as a target

for psychotropic

drugs

S-55

Rediscovering

Lithium

WS-10

Evidence for

brain stimula-

tion methods in

schizophrenia

S-53

Suicidal

behavior:

Neurobiological

and genetic

determinants

15:30

16:00

16:30

Coffee Break

17:00

FC-12

Schizophrenia

TFS-09

Providing acute

inpatient care

for children,

adolescents and

young adults

from a men’s

mental health

perspective

S-54

Lithium as a

neuroprotective

agent: When

and how?

FC-13

Genetics

FC-11

Inflammation

FC-14

Neuroimaging 2

FC-15

Addictive

disorders

17:30

18:00

18:30

Registration Counter

08:00–18:30

Poster Exhibition

09:00–17:00

Technical Exhibition

09:00–17:00